The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-Disciplinary Collaboration
creating positive experiences and outcomes.


Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.



Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.

350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

Havn Life Sciences partners with veterans mental health non-profit, Westwood Institute

Westwood Institute founder, Dr. Marvin Westwood will work with Havn Life’s research team to develop best practices for combining therapy and psychedelic interventions for veterans. …

Read More →
Press Releases

Havn Life attracts international drug science and policy expert, joins UK policy reform group

Havn Life has joined the UK-based Conservative Drug Policy Reform Group (CDPRG), a group organized to benefit drug policy-making The Havn Life Advisory Board adds …

Read More →
Press Releases

Havn Life Sciences announces $5.46 million warrant exercise

Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP) (the “Company” or “Havn Life”) is pleased to announce that 10,927,856 common …

Read More →
Scroll to Top